| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Institute of Endocrinology, University Clinical Centre (D.M., V.P., M.D., D.M.), Belgrade Yugoslavia Y-11000; and Department of Physiology (C.D.) and Medicine (F.F.C.), School of Medicine, Santiago de Compostela University, Santiago de Compostela, Spain E-15780
Address all correspondence and requests for reprints to: F. F. Casanueva, P.O. Box 563, Santiago de Compostela, Spain E-15780. E-mail: meffcasa{at}uscmail.usc.es
Either spontaneous or pharmacological stimulated GH secretion is reduced with advanced age. This observation is an added difficulty for the biochemical diagnosis of GH deficiency in adults. Furthermore, the combined administration of saturating doses of GH-releasing hormone (GHRH) plus GH-releasing hexapeptide (GHRP)-6 is nowadays the most effective GH-releasing stimulus tested in a variety of settings related to altered somatotroph function. To understand whether the GH discharge elicited by the combined stimulus declines with age, 26 normal subjects of both sexes, divided into 3 age groups [adults 1940 yr; aged 4665 yr; and very old (7596 yr) subjects] were studied. They were administered iv, as bolus and in combination, 90 µg GHRH plus 90 µg GHRP-6.
In the three groups, the combined administration of GHRH plus GHRP-6 elicited a GH area under the curve (µg/L per 120 min) of 3,127 ± 262, 3,409 ± 573, and 4,655 ± 737 for adults, aged, and very old subjects, respectively (nonsignificant differences). The mean GH peak was 47.5 ± 4.5 µg/L for adults, 52.9 ± 8.4 µg/L for aged subjects, and 76.0 ± 11.7 for very old subjects (nonsignificant differences). Individually examined, there were no nonresponders to the combined stimulus, and all subjects (independently of age) showed a GH peak over 25 µg/L (the lowest peak was 27.3 µg/L, and the highest peak was 119.2 µg/L).
In conclusion, the GHRH plus GHRP-6-induced GH release is well preserved in aged and very old subjects, which suggests that the GH secretory capability of the combined test is not reduced by age. This combined test may be useful for the diagnosis of GH-deficient states in adults.
This article has been cited by other articles:
![]() |
K. Chihara, A. Shimatsu, N. Hizuka, T. Tanaka, Y. Seino, Y. Katofor, and the KP-102 Study Group A simple diagnostic test using GH-releasing peptide-2 in adult GH deficiency Eur. J. Endocrinol., July 1, 2007; 157(1): 19 - 27. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gasperi, G. Aimaretti, G. Scarcello, G. Corneli, C. Cosci, E. Arvat, E. Martino, and E. Ghigo Low Dose Hexarelin and Growth Hormone (GH)-Releasing Hormone as a Diagnostic Tool for the Diagnosis of GH Deficiency in Adults: Comparison with Insulin-Induced Hypoglycemia Test J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2633 - 2637. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |